KELLY WOODFORD: Open Payments
NPI 1447505862 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 30 payments from 18 companies in 2025. Trend: 2023 $750 · 2024 $510 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 4 | $60 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| ABBVIE INC. | 2 | $50 |
| Gilead Sciences, Inc. | 3 | $48 |
| SOBI, INC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Caris MPI, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $26 |
Products named: KEYTRUDA, VENCLEXTA, Doptelet, XTANDI, KISQALI, OJJAARA, ENHERTU, MI CANCER SEEK.
Industry payments across MO — which companies pay providers there.
